Jeanine Ballard

1.3k total citations
19 papers, 383 citations indexed

About

Jeanine Ballard is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jeanine Ballard has authored 19 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jeanine Ballard's work include Pharmacogenetics and Drug Metabolism (4 papers), Ion channel regulation and function (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Jeanine Ballard is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Ion channel regulation and function (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Jeanine Ballard collaborates with scholars based in United States, United Kingdom and China. Jeanine Ballard's co-authors include Thomayant Prueksaritanont, Christopher R. Gibson, Jerome Hochman, Xiaoyan Chu, Tamara D. Cabalu, Donghui Cui, Ka Lai Yee, Richard L. Kraus, Yuxing Li and Cuyue Tang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Hepatology and Science Translational Medicine.

In The Last Decade

Jeanine Ballard

18 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeanine Ballard United States 9 152 112 99 59 57 19 383
Susanna Tse United States 14 146 1.0× 118 1.1× 88 0.9× 40 0.7× 33 0.6× 26 474
Lisa A. Shipley United States 12 193 1.3× 235 2.1× 138 1.4× 33 0.6× 58 1.0× 22 581
Yoshinori Nagata Japan 10 79 0.5× 84 0.8× 234 2.4× 54 0.9× 112 2.0× 11 421
Lucie Krausová Czechia 4 182 1.2× 107 1.0× 79 0.8× 48 0.8× 31 0.5× 5 494
Loren Berry United States 13 284 1.9× 237 2.1× 132 1.3× 46 0.8× 40 0.7× 20 694
James E. Grace United States 13 145 1.0× 152 1.4× 82 0.8× 45 0.8× 33 0.6× 21 555
Majid Vakilynejad United States 9 270 1.8× 76 0.7× 76 0.8× 42 0.7× 21 0.4× 28 586
Monique Schmitt Switzerland 11 109 0.7× 113 1.0× 83 0.8× 21 0.4× 61 1.1× 23 607
Nancy Van Osselaer Belgium 18 207 1.4× 106 0.9× 207 2.1× 88 1.5× 75 1.3× 30 936
Michal Bitman Czechia 5 170 1.1× 78 0.7× 50 0.5× 47 0.8× 43 0.8× 6 457

Countries citing papers authored by Jeanine Ballard

Since Specialization
Citations

This map shows the geographic impact of Jeanine Ballard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanine Ballard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanine Ballard more than expected).

Fields of papers citing papers by Jeanine Ballard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanine Ballard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanine Ballard. The network helps show where Jeanine Ballard may publish in the future.

Co-authorship network of co-authors of Jeanine Ballard

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanine Ballard. A scholar is included among the top collaborators of Jeanine Ballard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanine Ballard. Jeanine Ballard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Anjani, Qonita Kurnia, Ashley R. Johnson, Akmal Hidayat Bin Sabri, et al.. (2025). Delivery of Islatravir via High Drug‐Load, Long‐acting Microarray Patches for the Prevention or Treatment of Human Immunodeficiency Virus. Advanced Healthcare Materials. 14(7). e2403615–e2403615. 1 indexed citations
3.
Kohnz, Rebecca A., Dan Zhou, Bin Lou, et al.. (2025). Elucidation of Mechanism of Action in Drug Invention: Using Stable Isotope Tracers to Unravel Biochemical Kinetics. Pharmacology Research & Perspectives. 13(3). e70099–e70099. 1 indexed citations
4.
Maddess, Matthew L., David L. Sloman, Xiaoshen Ma, et al.. (2023). Abstract B074: Discovery of MK-1084, a low dose selective clinical stage KRAS G12C inhibitor. Molecular Cancer Therapeutics. 22(12_Supplement). B074–B074. 1 indexed citations
5.
Johnson, Ashley R., et al.. (2023). A Retrospective Analysis of Preclinical and Clinical Pharmacokinetics from Administration of Long-Acting Aqueous Suspensions. Pharmaceutical Research. 40(7). 1641–1656. 7 indexed citations
6.
Teng, Shu‐Wen, Michael J. Hafey, Jeanine Ballard, et al.. (2022). Physiologically-based modeling of cholate disposition in beagle dog with and without treatment of the liver transporter inhibitor simeprevir. Computational Toxicology. 22. 100224–100224. 1 indexed citations
7.
Roecker, Anthony J., M. E. Layton, Michael J. Kelly, et al.. (2021). Discovery of Arylsulfonamide Na v 1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile. ACS Medicinal Chemistry Letters. 12(6). 1038–1049. 8 indexed citations
8.
Ballard, Jeanine, Joshua D. Vardigan, Fuqiang Zhao, et al.. (2021). Translational Pharmacokinetic–Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose. Frontiers in Pharmacology. 12. 786078–786078. 5 indexed citations
9.
Patel, Munjal, Jeanine Ballard, Guoxin Wu, et al.. (2021). In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated Platform. SLAS DISCOVERY. 26(5). 642–654. 4 indexed citations
10.
Kraus, Richard L., Fuqiang Zhao, Dan Zhou, et al.. (2021). Na v 1.7 target modulation and efficacy can be measured in nonhuman primate assays. Science Translational Medicine. 13(594). 15 indexed citations
11.
Ballard, Jeanine, Joshua D. Vardigan, Fuqiang Zhao, et al.. (2020). Application of Pharmacokinetic-Pharmacodynamic Modeling to Inform Translation of In Vitro NaV1.7 Inhibition to In Vivo Pharmacological Response in Non-human Primate. Pharmaceutical Research. 37(10). 181–181. 4 indexed citations
12.
Vardigan, Joshua D., Andrea K. Houghton, Henry S. Lange, et al.. (2018). Pharmacological validation of a novel nonhuman primate measure of thermal responsivity with utility for predicting analgesic effects. Journal of Pain Research. Volume 11. 735–741. 10 indexed citations
13.
Stoch, S. Aubrey, Jeanine Ballard, Christopher R. Gibson, et al.. (2016). Coadministration of Rifampin Significantly Reduces Odanacatib Concentrations in Healthy Subjects. The Journal of Clinical Pharmacology. 57(1). 110–117. 2 indexed citations
14.
Sandhu, Punam, Junghoon Lee, Jeanine Ballard, et al.. (2016). P4‐036: Pharmacokinetics and Pharmacodynamics to Support Clinical Studies of MK‐8719: an O‐Glcnacase Inhibitor for Progressive Supranuclear Palsy. Alzheimer s & Dementia. 12(7S_Part_21). 20 indexed citations
15.
Marcantonio, Eugene E., Jeanine Ballard, Christopher R. Gibson, et al.. (2014). Prednisone has no effect on the pharmacokinetics of CYP3A4 metabolized drugs – midazolam and odanacatib. The Journal of Clinical Pharmacology. 54(11). 1280–1289. 20 indexed citations
16.
Prueksaritanont, Thomayant, Xiaoyan Chu, Christopher R. Gibson, et al.. (2013). Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective. The AAPS Journal. 15(3). 629–645. 192 indexed citations
17.
Uebele, Victor N., Anthony L. Gotter, Cindy E. Nuss, et al.. (2009). Antagonism of T-type calcium channels inhibits high-fat diet–induced weight gain in mice. Journal of Clinical Investigation. 119(6). 1659–1667. 61 indexed citations
18.
Ballard, Jeanine, et al.. (2007). Hepatic Metabolism of MK-0457, a Potent Aurora Kinase Inhibitor: Interspecies Comparison and Role of Human Cytochrome P450 and Flavin-Containing Monooxygenase. Drug Metabolism and Disposition. 35(9). 1447–1451. 14 indexed citations
19.
Seiwert, Scott D., Steven W. Andrews, Hua Tan, et al.. (2006). 750 Preclinical characteristics of ITMN-B, an orally active inhibitor of the HCV NS3/4A protease nominated for preclinical development. Journal of Hepatology. 44. S278–S278. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanna Tse Breakdown of academic impact, for papers by Lisa A. Shipley Breakdown of academic impact, for papers by Yoshinori Nagata Breakdown of academic impact, for papers by Lucie Krausová Breakdown of academic impact, for papers by Loren Berry Breakdown of academic impact, for papers by James E. Grace Breakdown of academic impact, for papers by Majid Vakilynejad Breakdown of academic impact, for papers by Monique Schmitt Breakdown of academic impact, for papers by Nancy Van Osselaer Breakdown of academic impact, for papers by Michal Bitman
Rankless by CCL
2026